Dearborn Partners LLC Johnson & Johnson Transaction History

Dearborn Partners LLC

$2.42 Billion
Q3 2024

A detailed history of Dearborn Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Dearborn Partners LLC holds 108,980 shares of JNJ stock, worth $16.9 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

108,980

Previous 109,547 0.52%

Holding current value

$16.9 Million

Previous $16 Million 10.31%

% of portfolio

0.73%

Previous 0.7%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$145.48 - $167.38 $82,487 - $94,904	-567 Reduced 0.52%	108,980 $17.7 Million
Q2 2024 Jul 26, 2024	SELL	$144.38 - $157.78 $240,825 - $263,177	-1,668 Reduced 1.5%	109,547 $16 Million
Q1 2024 May 08, 2024	SELL	$155.22 - $162.74 $100,116 - $104,967	-645 Reduced 0.58%	111,215 $17.6 Million
Q4 2023 Jan 26, 2024	SELL	$145.6 - $158.88 $63,918 - $69,748	-439 Reduced 0.39%	111,860 $17.5 Million
Q3 2023 Nov 01, 2023	SELL	$155.75 - $174.48 $41,585 - $46,586	-267 Reduced 0.24%	112,299 $17.5 Million
Q2 2023 Aug 03, 2023	SELL	$154.35 - $166.11 $8.06 Million - $8.67 Million	-52,188 Reduced 31.68%	112,566 $18.6 Million
Q1 2023 May 04, 2023	BUY	$151.05 - $180.26 $497,105 - $593,235	3,291 Added 2.04%	164,754 $25.5 Million
Q4 2022 Feb 02, 2023	SELL	$160.2 - $179.79 $74,172 - $83,242	-463 Reduced 0.29%	161,463 $28.5 Million
Q3 2022 Oct 25, 2022	BUY	$161.33 - $179.52 $6,130 - $6,821	38 Added 0.02%	161,926 $26.5 Million
Q2 2022 Jul 20, 2022	SELL	$168.19 - $186.01 $456,467 - $504,831	-2,714 Reduced 1.65%	161,888 $28.7 Million
Q1 2022 May 04, 2022	SELL	$158.14 - $179.59 $27.1 Million - $30.8 Million	-171,678 Reduced 51.05%	164,602 $29.2 Million
Q4 2021 Jan 28, 2022	SELL	$155.93 - $173.01 $536,243 - $594,981	-3,439 Reduced 1.01%	336,280 $57.5 Million
Q3 2021 Oct 27, 2021	BUY	$161.5 - $179.47 $102,875 - $114,322	637 Added 0.19%	339,719 $54.9 Million
Q2 2021 Jul 26, 2021	BUY	$159.48 - $171.07 $279,090 - $299,372	1,750 Added 0.52%	339,082 $55.9 Million
Q1 2021 Apr 29, 2021	BUY	$153.07 - $170.48 $208,940 - $232,705	1,365 Added 0.41%	337,332 $55.4 Million
Q4 2020 Jan 27, 2021	BUY	$137.11 - $157.38 $1.71 Million - $1.96 Million	12,463 Added 3.85%	335,967 $52.9 Million
Q3 2020 Oct 20, 2020	SELL	$140.38 - $153.83 $3,509 - $3,845	-25 Reduced 0.01%	323,504 $48.2 Million
Q2 2020 Jul 30, 2020	SELL	$128.81 - $155.51 $873,975 - $1.06 Million	-6,785 Reduced 2.05%	323,529 $45.5 Million
Q1 2020 May 11, 2020	BUY	$111.14 - $153.99 $93,913 - $130,121	845 Added 0.26%	330,314 $43.3 Million
Q4 2019 Jan 28, 2020	BUY	$127.5 - $146.44 $2.99 Million - $3.43 Million	23,448 Added 7.66%	329,469 $48.1 Million
Q3 2019 Oct 29, 2019	BUY	$126.95 - $142.14 $341,368 - $382,214	2,689 Added 0.89%	306,021 $39.6 Million
Q2 2019 Jul 29, 2019	BUY	$131.15 - $144.24 $923,427 - $1.02 Million	7,041 Added 2.38%	303,332 $42.2 Million
Q1 2019 May 01, 2019	BUY	$125.72 - $139.79 $418,019 - $464,801	3,325 Added 1.13%	296,291 $41.4 Million
Q4 2018 Feb 04, 2019	BUY	$122.84 - $147.84 $1.08 Million - $1.3 Million	8,763 Added 3.08%	292,966 $37.8 Million
Q3 2018 Oct 24, 2018	BUY	$121.58 - $142.88 $745,650 - $876,283	6,133 Added 2.21%	284,203 $39.3 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $946,722 - $1.04 Million	-7,929 Reduced 2.77%	278,070 $33.7 Million
Q1 2018 May 01, 2018	SELL	$125.1 - $148.14 $1.21 Million - $1.44 Million	-9,702 Reduced 3.28%	285,999 $36.7 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $793,356 - $868,326	-6,046 Reduced 2.0%	295,701 $41.3 Million
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $1.04 Million - $1.08 Million	-8,005 Reduced 2.58%	301,747 $39.2 Million
Q2 2017 Aug 09, 2017	BUY	N/A	309,752	309,752 $41 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Account

Dearborn Partners LLC Johnson & Johnson Transaction History